QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)

$5.18 0.11 (2.1696%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 63

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) News Sources

CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

28-04-2026

yahoo.com

Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026

30-04-2026

yahoo.com

Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results

07-05-2026

yahoo.com

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

04-06-2026

yahoo.com

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

16-06-2026

yahoo.com

Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003

18-06-2026

yahoo.com

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome

23-06-2026

yahoo.com

Quoin Pharmaceuticals Receives U.S. Notice of Allowance for Patent Covering Combination Treatment for Netherton Syndrome

30-06-2026

yahoo.com

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome

09-07-2026

yahoo.com

Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results

14-08-2026

yahoo.com

QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) Sentiment Trend

0 25 50 75 100 56 64 60 80 54 60 76 59 52 66 28-04-2026 30-04-2026 07-05-2026 04-06-2026 16-06-2026 18-06-2026 23-06-2026 30-06-2026 09-07-2026 14-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) FAQs

toggle

What is the current price of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?

The current price of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is $5.18.


toggle

QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) absolute price change since previous trading day?

The absolute price change of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) since the previous trading day is $0.11.


toggle

QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) percentage price change since previous trading day?

The percentage price change of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) since the previous trading day is 2.1696%.


toggle

What is the most recent average sentiment score for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?

The most recent average sentiment score for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is 63 out of 100.


toggle

What is the most recent average sentiment for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?

The most recent sentiment for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is .


SEC-8K** Filing Available For QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.